IRIS UniCatt

Trecarichi, Enrico Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.249
EU - Europa 5.123
AS - Asia 3.696
SA - Sud America 627
Continente sconosciuto - Info sul continente non disponibili 157
AF - Africa 69
OC - Oceania 8
Totale 14.929
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.080
DE - Germania 2.592
SG - Singapore 1.436
CN - Cina 1.341
SE - Svezia 545
IT - Italia 494
BR - Brasile 469
FR - Francia 344
UA - Ucraina 297
GB - Regno Unito 294
VN - Vietnam 247
IE - Irlanda 138
BD - Bangladesh 113
IN - India 112
TR - Turchia 96
FI - Finlandia 92
ID - Indonesia 89
PL - Polonia 86
CA - Canada 77
RU - Federazione Russa 72
AR - Argentina 58
HK - Hong Kong 44
MX - Messico 44
JP - Giappone 40
NL - Olanda 31
CO - Colombia 30
IQ - Iraq 30
BE - Belgio 25
EC - Ecuador 25
VE - Venezuela 19
ES - Italia 16
JM - Giamaica 14
SA - Arabia Saudita 14
ZA - Sudafrica 14
CR - Costa Rica 13
PK - Pakistan 13
RO - Romania 13
AT - Austria 11
IR - Iran 11
PH - Filippine 11
IL - Israele 9
KR - Corea 9
AZ - Azerbaigian 8
CH - Svizzera 8
CI - Costa d'Avorio 8
MY - Malesia 8
NP - Nepal 8
AU - Australia 7
JO - Giordania 7
KZ - Kazakistan 7
LT - Lituania 7
MA - Marocco 7
PE - Perù 7
UZ - Uzbekistan 7
BG - Bulgaria 6
CZ - Repubblica Ceca 6
DZ - Algeria 6
EG - Egitto 6
EU - Europa 6
KE - Kenya 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
CL - Cile 5
HU - Ungheria 5
NI - Nicaragua 5
RS - Serbia 5
TN - Tunisia 5
TW - Taiwan 5
UY - Uruguay 5
VA - Santa Sede (Città del Vaticano) 5
AL - Albania 4
ET - Etiopia 4
LV - Lettonia 4
PY - Paraguay 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BN - Brunei Darussalam 3
HN - Honduras 3
HR - Croazia 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
OM - Oman 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BZ - Belize 2
CM - Camerun 2
CY - Cipro 2
DJ - Gibuti 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GD - Grenada 2
GR - Grecia 2
GT - Guatemala 2
ME - Montenegro 2
MU - Mauritius 2
Totale 14.764
Salva come PNG Salva come JPEG
Città #
Singapore 790
Ashburn 581
Chandler 552
San Jose 481
Hangzhou 441
Jacksonville 209
Beijing 206
Nürnberg 202
San Mateo 153
Ann Arbor 144
Dublin 136
Nanjing 136
Dearborn 118
New York 118
Los Angeles 108
Jakarta 81
Milan 81
Wilmington 81
Izmir 75
Ho Chi Minh City 74
Lauterbourg 74
Council Bluffs 68
Hanoi 68
Munich 64
Boston 63
Woodbridge 63
The Dalles 62
Lawrence 56
Houston 55
Kraków 55
Marseille 55
Hefei 53
Moscow 53
Frankfurt am Main 52
Nanchang 52
Buffalo 47
Chicago 46
Rome 46
Cattolica 45
Redwood City 45
São Paulo 42
Dallas 40
Seattle 39
Hong Kong 38
Santa Clara 38
Bremen 37
Tokyo 33
Kunming 31
Tianjin 29
Shenyang 27
Brussels 25
Brooklyn 24
Shanghai 24
Toronto 24
Orem 23
Boardman 22
Mountain View 22
Atlanta 21
Hebei 21
Helsinki 21
Princeton 21
Norwalk 20
Warsaw 19
Changsha 18
Guangzhou 18
Leawood 17
Redmond 17
Lancaster 16
Fairfield 15
London 15
Mexico City 15
Montreal 15
Rio de Janeiro 15
University Park 15
Fremont 14
Jinan 14
Phoenix 14
Zhengzhou 14
Augusta 13
Denver 13
Naples 13
Belo Horizonte 12
Costa Mesa 12
Da Nang 12
Hải Dương 12
Paris 12
Stockholm 12
Baghdad 11
Brasília 11
Jiaxing 11
Nuremberg 11
Chennai 10
Kent 10
Manchester 10
Auburn Hills 9
Hyderabad 9
Philadelphia 9
Roubaix 9
Abidjan 8
Columbus 8
Totale 6.999
Salva come PNG Salva come JPEG
Nome #
Factors associated with mortality in bacteremic patients with haematologic malignancies 533
Factors associated with mortality in bacteremic patients with hematologic malignancies. 385
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 365
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 360
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study 322
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: An observational study 312
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 311
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study 303
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. 293
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. 270
Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome 247
Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis 237
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 236
Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. 232
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 228
Factors associated with mortality in bacteremic patients with hematologic malignancies. 225
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 208
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 203
High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis caused by staphylococcal small-colony variants 202
Safety and effectiveness of transvenous lead extraction in octogenarians 201
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 201
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 199
Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae 194
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 194
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 189
Tuberculous spondylodiscitis: epidemiology, clinical features, treatment, and outcome 189
Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia 185
Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact 185
The effect of polymorphisms in candidate genes on the long-term risk of lipodystrophy and dyslipidemia in HIV-infected white patients starting antiretroviral therapy 184
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 184
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 181
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 175
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae 174
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 171
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 170
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 169
Mortality in patients with early- or late-onset candidaemia 167
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 167
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 165
Esthesioneuroblastoma in an HIV-1 Infected Patient: Case Report 165
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 164
Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes 163
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 160
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 157
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality 156
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry 156
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 156
Microbiologic and clinical characteristics of biofilm-forming Candida parapsilosis isolates associated with fungaemia and their impact on mortality 152
Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals. 151
Mortality in patients with early- or late-onset candidaemia 151
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: A multinational pre-registered cohort study 150
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study 148
Epidemiological and clinical features of pyogenic spondylodiscitis. 145
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study 145
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study 144
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey 141
Utility, acceptability and applicability of a nucleic acid amplification test in comparison with a syndromic approach in the management of sexually transmitted diseases at Mulago National Referral Hospital in Uganda (ASTRHA): Protocol for an open-label, randomised controlled trial 138
Uncommon yeast infections in hematological patients: from diagnosis to treatment 138
Mortality in patients, with early-or late-onset candidaemia 138
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 138
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 137
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 129
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 129
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria 127
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 119
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 118
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study 116
Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience 113
Isavuconazole-Animal Data and Clinical Data 113
When Viruses Meet Fungi: Tackling the Enemies in Hematology 113
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 109
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 109
Therapeutic options for carbapenem-resistant Enterobacteriaceae infections 108
Fluconazole use as an important risk factor in the emergence of fluconazole-resistant Candida glabrata fungemia 108
Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey 106
Mortality in patients with early- or late-onset candidaemia 89
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia 87
An autochthonous case of cutaneous bacillary angiomatosis not related to major immunosuppression: An emerging or overlooked disease? 84
Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections 82
Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections 80
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 78
COVID-19-associated pulmonary aspergillosis in intensive care unit: A real-life experience 75
New advances in management and treatment of cardiac implantable electronic devices infections 73
Bloodstream infections caused by extended-spectrum-β-lactamase- producing Escherichia coli: Risk factors for inadequate initial antimicrobial therapy 70
Cefiderocol therapy among immunocompromised adult patients: a descriptive analysis from a prospective, multicentre cohort study 21
How long is enough? Evidence gaps and research priorities for antibiotic duration in immunocompromised hosts 20
Lopinavir/ritonavir and darunavir/cobicistat in hospitalized covid-19 patients: Findings from the multicenter italian corist study 19
Prevalence of Antibiotic Resistance Over Time in a Third-Level University Hospital 15
RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 14
Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape 13
The three facets of the SARS-CoV-2 pandemic during the first two waves in the northern, central, and southern Italy 11
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 11
Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium 11
Evolution of in-hospital patient characteristics and predictors of death in the COVID-19 pandemic across four waves: are they moving targets with implications for patient care? 9
Omic insights into various ceftazidime-avibactam-resistant Klebsiella pneumoniae isolates from two southern Italian regions 9
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study 8
New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae 7
Spike-specific T-cell responses in patients with COVID-19 successfully treated with neutralizing monoclonal antibodies against SARS-CoV-2 7
Touching Base with Some Mediterranean Diseases of Interest from Paradigmatic Cases at the “Magna Graecia” University Unit of Infectious Diseases: A Didascalic Review 6
Sars-cov-2: Some aspects of molecular evolution, cellular pathogenesis, and immune system mechanism elusion 4
Totale 14.929
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.943
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.943
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022643 0 0 0 48 52 39 12 140 38 63 116 135
2022/20231.567 191 223 115 246 89 196 86 126 176 29 69 21
2023/2024649 39 198 13 26 19 91 48 23 9 25 81 77
2024/20251.371 50 35 109 30 171 51 41 56 213 99 280 236
2025/20263.910 568 97 209 442 759 182 658 197 195 263 179 161
2026/20271.121 175 525 310 111 0 0 0 0 0 0 0 0
Totale 14.929